GLPG logo

Galapagos NV

GLPG

GLPG: Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

more

Show GLPG Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of GLPG by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GLPG's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Aug. 08, 2023
  • Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jun. 06, 2023
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 31, 2023
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of diseases May. 24, 2022
  • Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 11, 2022
  • Patent Title: Pyrrolopyrimidine and pyrrolopyridine derivatives Oct. 05, 2021
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 27, 2021
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases May. 11, 2021
  • Patent Title: 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Mar. 09, 2021
  • Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 16, 2021
  • Patent Title: 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts 4 and 5 inhibitors for treating e.g. osteoarthritis Nov. 10, 2020
  • Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 07, 2020
  • Patent Title: Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 25, 2020
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Feb. 25, 2020
  • Patent Title: 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts 4 and 5 inhibitors for treating e.g. osteoarthritis Feb. 04, 2020
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 07, 2020
  • Patent Title: 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-b]pyridin-3-yl]-nicotinonitrile derivatives and their use as irak inhibitors Dec. 17, 2019
  • Patent Title: Pharmaceutical compositions for the treatment of inflammatory disorders Dec. 03, 2019
  • Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Nov. 26, 2019
  • Patent Title: Methods for the treatment of cardiovascular disorders Aug. 13, 2019
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jun. 25, 2019
  • Patent Title: Compounds useful for the treatment of degenerative and inflammatory diseases Feb. 19, 2019
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jan. 15, 2019
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nov. 13, 2018
  • Patent Title: Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases Aug. 14, 2018
  • Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Aug. 14, 2018
  • Patent Title: Compound useful for the treatement of degenerative and inflammatory diseases Jun. 05, 2018
  • Patent Title: Methods of identifying compounds for the treatment of fibrosis by using s1pr5 Apr. 24, 2018
  • Patent Title: Methods and means for treatment of osteoarthritis Apr. 24, 2018
  • Patent Title: Methods for identifying compounds that inhibit g protein-coupled receptor (gpr84) agonist-stimulated chemotaxis Apr. 17, 2018
  • Patent Title: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis Mar. 27, 2018
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Feb. 20, 2018
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Jan. 16, 2018
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Oct. 24, 2017
  • Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists) Jul. 18, 2017
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jul. 18, 2017
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jun. 06, 2017
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Nov. 29, 2016
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Sep. 13, 2016
  • Patent Title: Compounds useful for the treatment of degenerative and inflammatory diseases Aug. 16, 2016
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Jul. 05, 2016
  • Patent Title: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders Jul. 05, 2016
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis May. 31, 2016
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Apr. 12, 2016
  • Patent Title: Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof Mar. 15, 2016
  • Patent Title: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 09, 2016
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Feb. 02, 2016
  • Patent Title: Compound useful for the treatment of degenerative and inflammatory diseases Jan. 26, 2016
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Sep. 15, 2015
  • Patent Title: Compounds and pharmaceutical compositions thereof for the treatment of proliferative disorders Jun. 23, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GLPG in WallStreetBets Daily Discussion

GLPG News

Recent insights relating to GLPG

CNBC Recommendations

Recent picks made for GLPG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GLPG

Corporate Flights

Flights by private jets registered to GLPG